Tonix Pharmaceuticals: Jeffrey Rosenfeld

Jeffrey Rosenfeld has been appointed as executive director of genomics and bioinformatics at Tonix Pharmaceuticals. He will direct the company's pharmacogenomics efforts, including the use of artificial intelligence, genome-wide association studies, and mathematical modeling to analyze patient outcomes in Tonix clinical trials. Rosenfeld joins the firm from the Rutgers Cancer Institute of New Jersey, where he was an assistant professor of pathology and laboratory medicine and manager of the biomedical informatics shared resource. He hold a BS in biology and an MS in biotechnology from the University of Pennsylvania and a PhD in biology from New York University.